NEW YORK (GenomeWeb News) – GenomOncology today said that it is collaborating with Roswell Park Cancer Institute to develop an informatics solution that will help users define actionable mutations in next-generation sequencing data.
The partners are co-developing a software platform that integrates laboratory information management systems and electronic health records, and provides a workflow that enables genomic analysts and pathologists to create actionable reports based on NGS results. They will demo the software at the Advances in Genome Biology & Technology conference this week, and at the United States & Canadian Academy of Pathology meeting in March.
As reported yesterday on GenomeWeb Daily News, GenomOncology is also working with Vanderbilt-Ingram to develop a genomics content management tool based on the institute's My Cancer Genome resource that will provide faster actionable results for cancer treatment.